Sales costs of China's Yunnan Baiyao Group 2014-2022
Yunnan Baiyao Group, one of the leading Chinese pharmaceutical enterprises, spent almost 4.2 billion yuan on sales and distribution in 2022, indicating a seven percent increase compared to the year before. The company is famous for its Chinese herbal remedy for promoting blood clotting and hemostasis.